Metabolic / Weight
GLP-3 (RT) 10mg / 20mg / 30mg
Also called Retatrutide
$45.49
$64.99
A next-generation triple-action research compound that engages three metabolic pathways simultaneously. Studied for its role in energy regulation, appetite signaling, and multi-receptor metabolic response. One of the most advanced metabolic tools available for preclinical research.
Purity ≥99% · Research Purposes Only
Dosage
In stock — ships within 2 business days.
Purity
≥ 99% (HPLC)
Form
Lyophilized Powder
Storage
-20°C, protect from light
Molecular Weight
Varies by compound
COA
Included with order
GLP-3 (RT)
$45.49
Certificate of Analysis
Independent third-party testing by Janoshik Laboratory
Janoshik Certified
99.210%
Purity
Test Results
| Retatrutide | 11.19 mg |
| Purity | 99.210% |
| Heavy Metals | Not Detected |
| Sterility | No Growth |
99.843%
Purity
Test Results
| Retatrutide | 22.41 mg |
| Purity | 99.843% |
| Heavy Metals | Not Detected |
| Sterility | No Growth |
Certificate of Analysis
Verified by Janoshik Laboratory
Compound Information
Technical specifications & storage requirements
Molecular Profile
What Is GLP-3 (RT)?
Triple receptor agonist engaging GLP-1, GIP, and glucagon pathways simultaneously. Features a C20 diacid fatty acid chain.
Classification
Synthetic Peptide (GLP-1/GIP/Glucagon Triple Agonist)
CAS Number
2381089-83-2
Molecular Weight
4,731 g/mol
Amino Acids
39
Form
Lyophilized Powder
Purity
≥ 99% (HPLC Verified)
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C
24+ months
Reconstituted
2–8°C
~30 days
For in vitro research and laboratory use only. Not for human or veterinary consumption.
Sources & References
Peer-reviewed research
NEW ENGLAND JOURNAL OF MEDICINE
Triple-hormone-receptor agonist retatrutide in a Phase 2 trial for obesity management
View Source THE LANCET
Phase 2 trial of retatrutide in adults with type 2 diabetes and overweight or obesity
View Source NATURE MEDICINE
Retatrutide for metabolic dysfunction-associated steatotic liver disease — Phase 2 findings
View Source